SEQUENCE-SPECIFIC DNA RECOMBINATION IN EUKARYOTIC CELLS

Sequence-specific recombination (SSR) of DNA in a eukaryotic cell, comprising introducing two DNA sequences (I, II) into a cell, and using an integrase (Int) to effect SSR, is new. Independent claims are also included for the following: (1) a nucleic acid comprising a 243 base pair sequence (IIII),...

Full description

Saved in:
Bibliographic Details
Main Authors ELKE LORBACH, NICOLE CHRIST, PETER DROEGE
Format Patent
LanguageEnglish
Portuguese
Published 27.01.2010
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
BEER
BIOCHEMISTRY
CARE OF BIRDS, FISHES, INSECTS
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NEW BREEDS OF ANIMALS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TRAPPING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Sequence-specific recombination (SSR) of DNA in a eukaryotic cell, comprising introducing two DNA sequences (I, II) into a cell, and using an integrase (Int) to effect SSR, is new. Independent claims are also included for the following: (1) a nucleic acid comprising a 243 base pair sequence (IIII), fully defined in the specification, or its derivatives; and (2) vector containing (III), or its derivatives, plus a therapeutic gene, or its derivatives. ACTIVITY : None given. MECHANISM OF ACTION : Gene therapy. No biological data is given.
Bibliography:Application Number: PT20060008807T